Replies to post #1062 on Cellectar Biosciences Inc (CLRB)

[d'anconia]

I agree. NVLT is WAY oversold.

As a student of history, NVLT's massive drop reminds me of HGSI's drop on 03/09/09 after issuing a negative press for their drug. It dropped from the 1.60s all the way down to .45 in a matter of a few days before starting it's run up.

It now trades at $31+.

I'm not saying that lightning will strike twice with NVLT.

However, what I am comfortable saying is that we are oversold at these levels, especially in light of what NVLT has in its pipeline.